AIM The aim of this article is to evaluate the rate of patients developing sustained elevated intraocular pressure (IOP) after ranibizumab (Lucentis) intravitreal (IVT) injections. DESIGN This is a retrospective study. PARTICIPANTS Charts of 192 consecutive patients receiving Lucentis for age-related macular degeneration (AMD) were retrospectively reviewed. MATERIALS AND METHODS We enroll...

BACKGROUND AND OBJECTIVE To assess the outcomes of intravitreal bevacizumab injection in the management of radiation maculopathy secondary to plaque radiotherapy, and to identify optimal treatment strategies. STUDY DESIGN A retrospective review of all choroidal melanoma patients at one referral center who were treated with plaque radiotherapy, subsequently developed radiation maculopathy, and...

PURPOSE To assess the efficacy and safety of intravitreal conbercept injections in patients with macular edema secondary to retinal vein occlusion (RVO). METHODS A prospective, Phase II clinical trial was performed on 60 patients with macular edema secondary to RVO. Thirty patients had branch RVO (BRVO) and 30 had central RVO (CRVO). Each patient received intravitreal injections of conbercept...

Purpose. To identify treatment preferences of patients with diabetic macular edema (DME) having undergone laser and intravitreal injections. Methods. Patients with DME who received lasers and injections were surveyed, measuring preferences toward specific treatments. 66/210 diabetic patients met the criteria for our survey assessing preference for lasers and/or injections, incorporating demogra...

Background — Intravitreal implants solve a number of serious problems arising in diseases the posterior segment eyeball. Unlike intravitreal injections, implant provides prolonged release pharmaceutical drug over time. The review presents characteristics existing systems for delivery: nanosystems, non-biodegradable and biodegradable implants. also highlights main advantages disadvantages variou...

PURPOSE To investigate the short-term efficacy and safety of intravitreal aflibercept in a case series of patients with diabetic macular edema (DME) refractory to ranibizumab or bevacizumab. DESIGN A retrospective chart review. METHODS From September 2013 to March 2016, we identified patients with DME who developed resistance to bevacizumab or ranibizumab. Three monthly intravitreal afliber...

PURPOSE To present the functional and anatomic changes after intravitreal bevacizumab in eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO). DESIGN The study was a retrospective study. MATERIALS AND METHODS The study included 31 patients with ME due to BRVO. We compared the examination findings of patients with ME before and after intravitreal bevacizumab therapy at 12...

Background: This study aimed to evaluate the clinical characteristics and changes in number of patients receiving intravitreal injections (IVIs) at a tertiary hospital during coronavirus disease 2019 (COVID-19) pandemic as compared pre-pandemic period.
 Methods: retrospective, cross-sectional included 3,211 with retinal disease, who received IVIs anti-vascular endothelial growth factor (an...